YU33796A - Farmaceutska smeša - Google Patents
Farmaceutska smešaInfo
- Publication number
- YU33796A YU33796A YU33796A YU33796A YU33796A YU 33796 A YU33796 A YU 33796A YU 33796 A YU33796 A YU 33796A YU 33796 A YU33796 A YU 33796A YU 33796 A YU33796 A YU 33796A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- pharmaceutical mixture
- compositions
- monoglycerides
- bioavailability
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Prikazane su smeše koje povećavaju biološku upotrebljivost inhibitora proteinaza. Ove smeše sastoje se od farmaceutski prihvatljivog nosača koji obuhvata monogliceride masnih kiselina osrednjih lanaca.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46849395A | 1995-06-06 | 1995-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU33796A true YU33796A (sh) | 1998-07-10 |
YU49308B YU49308B (sh) | 2005-06-10 |
Family
ID=23860032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU33796A YU49308B (sh) | 1995-06-06 | 1996-06-05 | Farmaceutske smeše |
Country Status (18)
Country | Link |
---|---|
US (1) | US6008228A (sh) |
KR (1) | KR100267437B1 (sh) |
AR (1) | AR002759A1 (sh) |
CO (1) | CO4700448A1 (sh) |
EG (1) | EG24294A (sh) |
HR (1) | HRP960271B1 (sh) |
MA (1) | MA23900A1 (sh) |
MY (1) | MY116525A (sh) |
PE (1) | PE4398A1 (sh) |
RO (1) | RO115113B1 (sh) |
SA (1) | SA96170162B1 (sh) |
SI (1) | SI0831826T1 (sh) |
SV (1) | SV1996000040A (sh) |
TW (1) | TW452492B (sh) |
UA (1) | UA44316C2 (sh) |
UY (1) | UY24248A1 (sh) |
YU (1) | YU49308B (sh) |
ZA (1) | ZA964448B (sh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
US5858401A (en) * | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
US6353538B1 (en) * | 1999-05-13 | 2002-03-05 | Intel Corporation | Protective cover and packaging for multi-chip memory modules |
US7527807B2 (en) | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
US6248360B1 (en) | 2000-06-21 | 2001-06-19 | International Health Management Associates, Inc. | Complexes to improve oral absorption of poorly absorbable antibiotics |
AU2002230918B2 (en) * | 2000-10-31 | 2006-12-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Oral self-emulsifying formulations of pyranone protease inhibitors |
CA2477321A1 (en) * | 2002-02-25 | 2003-08-28 | Lyfjathroun Hf | Absorption enhancing agent |
US7157489B2 (en) * | 2002-03-12 | 2007-01-02 | The Board Of Trustees Of The University Of Illinois | HIV protease inhibitors |
BR0202252A (pt) * | 2002-06-12 | 2004-06-29 | Cristalia Prod Quimicos Farm | Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease |
US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
AU2004308712A1 (en) * | 2003-12-23 | 2005-07-14 | Tibotec Pharmaceuticals Ltd. | Self-microemulsifying drug delivery systems of a HIV protease inhibitor |
EP1877041A2 (en) * | 2005-04-29 | 2008-01-16 | Cubist Pharmaceuticals, Inc. | Therapeutic compositions |
US20100222311A1 (en) * | 2007-10-19 | 2010-09-02 | Purdue Research Foundation | Solid formulations of crystalline compounds |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4997851A (en) * | 1987-12-31 | 1991-03-05 | Isaacs Charles E | Antiviral and antibacterial activity of fatty acids and monoglycerides |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
US5354866A (en) * | 1989-05-23 | 1994-10-11 | Abbott Laboratories | Retroviral protease inhibiting compounds |
DE3919982A1 (de) * | 1989-06-19 | 1990-12-20 | Liedtke Pharmed Gmbh | Orale lipidarzneiform |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
EP0448091B1 (en) * | 1990-03-23 | 1998-08-05 | The Green Cross Corporation | Pharmaceutical composition containing slightly water-soluble drug |
US5114957A (en) * | 1990-05-08 | 1992-05-19 | Biodor U.S. Holding | Tocopherol-based antiviral agents and method of using same |
CA2056911C (en) * | 1990-12-11 | 1998-09-22 | Yuuichi Nagano | Hiv protease inhibitors |
ATE183099T1 (de) * | 1991-04-19 | 1999-08-15 | Lds Technologies Inc | Konvertierbare mikroemulsionsverbindungen |
GB9113872D0 (en) * | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
CN1071930A (zh) * | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
US5554728A (en) * | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
US5516784A (en) * | 1991-08-13 | 1996-05-14 | Schering Corporation | Anti-HIV (AIDS) agents |
AU662434B2 (en) * | 1992-08-07 | 1995-08-31 | Sankyo Company Limited | Peptides capable of inhibiting the activity of HIV protease, their preparation and their use |
JPH08502492A (ja) * | 1992-10-16 | 1996-03-19 | スミスクライン・ビーチャム・コーポレイション | 治療用ミクロエマルジョン |
JPH08502490A (ja) * | 1992-10-16 | 1996-03-19 | スミスクライン・ビーチャム・コーポレイション | 組成物 |
TW372972B (en) * | 1992-10-23 | 1999-11-01 | Novartis Ag | Antiretroviral acyl compounds |
US5538997A (en) * | 1993-03-12 | 1996-07-23 | Sandoz Ltd. | 2,4-diamino-3-hydroxycarboxylic acid derivatives |
US5318781A (en) * | 1993-04-06 | 1994-06-07 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
-
1996
- 1996-05-07 US US08/616,233 patent/US6008228A/en not_active Expired - Lifetime
- 1996-05-30 ZA ZA964448A patent/ZA964448B/xx unknown
- 1996-06-04 RO RO97-02248A patent/RO115113B1/ro unknown
- 1996-06-04 MY MYPI96002162A patent/MY116525A/en unknown
- 1996-06-04 AR ARP960102906A patent/AR002759A1/es unknown
- 1996-06-04 SI SI9630535T patent/SI0831826T1/xx unknown
- 1996-06-04 UA UA97125859A patent/UA44316C2/uk unknown
- 1996-06-04 KR KR1019970708905A patent/KR100267437B1/ko not_active IP Right Cessation
- 1996-06-05 PE PE1996000408A patent/PE4398A1/es not_active IP Right Cessation
- 1996-06-05 YU YU33796A patent/YU49308B/sh unknown
- 1996-06-05 SV SV1996000040A patent/SV1996000040A/es active IP Right Grant
- 1996-06-05 UY UY24248A patent/UY24248A1/es not_active IP Right Cessation
- 1996-06-06 HR HR960271A patent/HRP960271B1/xx not_active IP Right Cessation
- 1996-06-06 EG EG50896A patent/EG24294A/xx active
- 1996-06-06 CO CO96029448A patent/CO4700448A1/es unknown
- 1996-06-06 MA MA24271A patent/MA23900A1/fr unknown
- 1996-06-13 TW TW085107083A patent/TW452492B/zh not_active IP Right Cessation
- 1996-07-22 SA SA96170162A patent/SA96170162B1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
UY24248A1 (es) | 2000-12-29 |
HRP960271A2 (en) | 1997-12-31 |
ZA964448B (en) | 1996-12-06 |
RO115113B1 (ro) | 1999-11-30 |
TW452492B (en) | 2001-09-01 |
AR002759A1 (es) | 1998-04-29 |
KR100267437B1 (ko) | 2000-12-01 |
HRP960271B1 (en) | 2002-02-28 |
MA23900A1 (fr) | 1996-12-31 |
PE4398A1 (es) | 1998-02-28 |
EG24294A (en) | 2009-01-08 |
SI0831826T1 (en) | 2003-02-28 |
SV1996000040A (es) | 1997-03-19 |
US6008228A (en) | 1999-12-28 |
MY116525A (en) | 2004-02-28 |
YU49308B (sh) | 2005-06-10 |
CO4700448A1 (es) | 1998-12-29 |
SA96170162B1 (ar) | 2006-03-15 |
KR19990022425A (ko) | 1999-03-25 |
UA44316C2 (uk) | 2002-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU33796A (sh) | Farmaceutska smeša | |
BR9610842A (pt) | Composição farmacêutica compreendendo um inibidor de proteinase e um monoglicerídeo | |
DK1915993T3 (da) | Synergistiske kombinationer omfattende en renininhibitor til hjertekarsygdomme | |
DE59610329D1 (de) | Airblast-Zerstäuberdüse | |
NO994003L (no) | Farmasoytisk blanding | |
DK1123088T3 (da) | Sustained-release farmaceutiske formuleringer indeholdende en cGMP PDE-5 inhibitor | |
NO20001219D0 (no) | Blanding for medikament-administrasjon | |
GT200000183A (es) | Aminoacidos biciclicos como agentes farmaceuticos. | |
ATE218336T1 (de) | Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom | |
MY161871A (en) | Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester | |
ID26137A (id) | Komposisi farmasi baru dari uridin trifosfat | |
FI962073A (fi) | HIV-proteaasin estäjän prodrug-muotoja | |
ID28451A (id) | Trisiklik piperidin-δ3 sebagai bahan farmasi | |
ECSP961778A (es) | Composiciones que incrementan la biodisponibilidad de inhibidores de proteinasa | |
HN1996000074A (es) | Formulaciones farmaceuticas | |
KR980003762U (ko) | 제품 브랜드의 고정 장치 | |
ITPD950134A0 (it) | Prodotto farmaceutico a base terpenica | |
KR970014369U (ko) | 역화 방지용 버너구조 |